RecruitingNCT05311137
Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population
Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community
Sponsor
Shanghai 10th People's Hospital
Enrollment
5,000 participants
Start Date
May 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria1
- atrial fibrillation patients；Ability to act autonomously, understand and sign informed consent；
Exclusion Criteria1
- none（All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up）
Interventions
PROCEDURERadiofrequency ablation
Combined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05311137
Related Trials
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations